Michael Koller

14.9k total citations · 2 hit papers
309 papers, 9.2k citations indexed

About

Michael Koller is a scholar working on Oncology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Koller has authored 309 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Oncology, 59 papers in Surgery and 48 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Koller's work include Cancer survivorship and care (61 papers), Health Systems, Economic Evaluations, Quality of Life (28 papers) and Clinical practice guidelines implementation (24 papers). Michael Koller is often cited by papers focused on Cancer survivorship and care (61 papers), Health Systems, Economic Evaluations, Quality of Life (28 papers) and Clinical practice guidelines implementation (24 papers). Michael Koller collaborates with scholars based in Germany, United Kingdom and Belgium. Michael Koller's co-authors include Florian Zeman, Marcel Wolbers, Ewout W. Steyerberg, W. Lorenz, Jane Blazeby, Peter Fayers, Neil Scott, Andrew Bottomley, Jacqueline C.M. Witteman and Monika Klinkhammer‐Schalke and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Koller

292 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Models With Competing Risks

2009 477 citations Michael Koller et al. profile →
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

2013 434 citations EC Inwald, Monika Klinkhammer‐Schalke et al. Breast Cancer Research and Treatment profile →

Peers

Countries citing papers authored by Michael Koller

Since Specialization

Citations

This map shows the geographic impact of Michael Koller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Koller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Koller more than expected).

Fields of papers citing papers by Michael Koller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Koller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Koller. The network helps show where Michael Koller may publish in the future.

Co-authorship network of co-authors of Michael Koller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Koller. A scholar is included among the top collaborators of Michael Koller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Koller. Michael Koller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using a harmonised study design and quantitative tool-box reveals major inconsistencies when investigating the main drivers of water and biofilm antibiotic resistomes in different rivers 2025 ·Journal of Hazardous Materials ·(unknown), Claudia Kolm, Rita Linke, (unknown), Michael Koller, Wolfgang Kandler, Clemens Kittinger, Gernot Zarfel, Andreas H. Farnleitner, Alexander K. T. Kirschner	1
2	The EORTC QLQ-F17 as a shortened version of the EORTC QLQ-C30 to assess self-reported functioning in cancer patients: investigating equivalence and psychometric properties in a randomized cross-over trial 2025 ·EClinicalMedicine ·Florian Zeman, Johannes M. Giesinger, Tobias Pukrop, Morten Aagaard Petersen, Mogens Grøenvold, Sandra Nolte, Dagmara Kuliś, Sunil Shrestha, Laurence Leysen, Kim Cocks, Corneel Coens, Georgios Ioannidis, Cecilia Pompili, Michael Koller	0
3	The Regensburg Dental Trauma Registry: Methodical Framework for the Systematic Collection of Dentoalveolar Trauma Data 2024 ·Journal of Clinical Medicine ·Matthias Widbiller, (unknown), Karolina Müller, Michael Koller, Torsten E. Reichert, Wolfgang Buchalla, (unknown)	0
4	Multimodal Treatment of Pleural Mesothelioma with Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy: Impact of Additive Chemotherapy 2024 ·Cancers ·Laura V. Klotz, (unknown), Karolina Müller, (unknown), (unknown), Michael Koller, Severin Schmid, (unknown), (unknown), Bernward Passlick, Hans‐Stefan Hofmann, H. Winter, Rudolf Hatz, Martin Eichhorn, Michael Ried	2
5	The complex intervention day hospice — a quality-assured study on the implementation, realization, and benefits with model character for Germany (IMPULS) using the example of “Day hospice Adiuvantes” 2024 ·BMC Palliative Care ·Ulrich Kaiser, Ursula Vehling‐Kaiser, (unknown), (unknown), (unknown), (unknown), (unknown), Michael Koller, Florian Kaiser	3
6	Outcome after cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy in patients with secondary pleural metastases 2023 ·Frontiers in Oncology ·(unknown), Julia Zimmermann, Severin Schmid, Bernward Passlick, (unknown), (unknown), H. Winter, Laura V. Klotz, Martin Eichhorn, (unknown), Karolina Müller, (unknown), Michael Koller, Hans‐Stefan Hofmann, Michael Ried	1
7	Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types 2023 ·European Journal of Cancer ·Jammbe Musoro, Corneel Coens, Mirjam A. G. Sprangers, Yvonne Brandberg, Mogens Grøenvold, Hans‐Henning Flechtner, Kim Cocks, Galina Velikova, Linda Dirven, Elfriede Greimel, Susanne Singer, Katarzyna Pogoda, Eva‐Maria Gamper, Samantha C. Sodergren, Alexander M.M. Eggermont, Michael Koller, Jaap C. Reijneveld, Martin Taphoorn, Madeleine King, Andrew Bottomley	64
8	Versorgungsnahe Daten für Versorgungsanalysen – Teil 3 des Manuals 2022 ·Das Gesundheitswesen ·Christof Veit, (unknown), Simone Wesselmann, Stephanie Stock, Claus-Dieter Heidecke, Christian Apfelbacher, Stefan Benz, Karsten Dreinhöfer, Michael Hauptmann, Falk Hoffmann, Wolfgang Hoffmann, Thomas Kaiser, Monika Klinkhammer‐Schalke, Michael Koller, Tanja Kostuj, Olaf Ortmann, Jochen Schmitt, Holger J. Schünemann, Max Geraedts	6
9	Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer 2022 ·European Journal of Cancer ·Kim Cocks, (unknown), Colin A. Johnson, Heike Schmidt, Michael Koller, Simone Oerlemans, Galina Velikova, Monica Pinto, Krzysztof A. Tomaszewski, Neil K. Aaronson, (unknown), (unknown), Deborah Fitzsimmons, Laura Grant, Mogens Grøenvold, Chloe Tolley, Sally Wheelwright, Andrew Bottomley	69
10	TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial 2022 ·Pharmaceutics ·(unknown), Florian Zeman, Michael Koller, (unknown), (unknown), Caroline T. Seebauer, Veronika Vielsmeier, Christopher Bohr, Thomas Kühnel	6
11	Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study 2021 ·Cancers ·Michael Ried, (unknown), (unknown), Karolina Müller, (unknown), Michael Koller, H. Winter, Laura V. Klotz, Rudolf Hatz, Julia Zimmermann, Bernward Passlick, Severin Schmid, (unknown), Martin Eichhorn, Hans‐Stefan Hofmann	12
12	Translation and cultural adaptation of EORTC QLQ-LC 29 into Nepalese language for lung cancer patients in Nepal 2020 ·Journal of Patient-Reported Outcomes ·Sunil Shrestha, Sudip Shrestha, Bhuvan KC, Binaya Sapkota, (unknown), Saval Khanal, Michael Koller	2
13	Reconstruction of chronic scapholunate dissociation with the modified scapholunate axis method (SLAM) 2019 ·Archives of Orthopaedic and Trauma Surgery ·Jüergen H. Dolderer, (unknown), S. Klein, Michael Koller, Lukas Prantl, Sebastian Geis	4
14	Phototherapy‐induced elevation of serum level of melanoma inhibitory activity 2019 ·Photodermatology Photoimmunology & Photomedicine ·(unknown), Florian Zeman, Michael Koller, Rolf‐Markus Szeimies, Mark Berneburg, Michael Landthaler, Anja‐Katrin Bosserhoff, Sigrid Karrer	3
15	A trauma network with centralized and local health care structures: Evaluating the effectiveness of the first certified Trauma Network of the German Society of Trauma Surgery 2018 ·PLoS ONE ·Antonio Ernstberger, Michael Koller, Florian Zeman, Maximilian Kerschbaum, (unknown), (unknown), Julika Loss, (unknown), Michael Nerlich	14
16	Focusing on cancer patients' intentions to use psychooncological support: A longitudinal, mixed‐methods study 2018 ·Psycho-Oncology ·Theresa Tondorf, (unknown), Sacha I. Rothschild, Michael Koller, Christoph Rochlitz, Alexander Kiss, Rainer Schaefert, Gunther Meinlschmidt, Sabina Hunziker, Diana Zwahlen	49
17	Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology 2017 ·Breast Cancer Research and Treatment ·EC Inwald, Olaf Ortmann, Michael Koller, Florian Zeman, Ferdinand Hofstädter, Matthias Evert, Gero Brockhoff, Monika Klinkhammer‐Schalke	26
18	A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial 2013 ·BMC Cancer ·Gabriel Glockzin, Justine Rochon, Dirk Arnold, Sven Arke Lang, Frank Klebl, Florian Zeman, Michael Koller, Hans J. Schlitt, Pompiliu Piso	35
19	Defining a degradation cost function for optimal control of a battery energy storage system 2013 ·Michael Koller, Theodor Borsche, Andreas Ulbig, Göran Andersson	128
20	The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database 2008 ·Journal of Clinical Epidemiology ·Neil Scott, Peter Fayers, Neil K. Aaronson, Andrew Bottomley, Alexander de Graeff, Mogens Grøenvold, Michael Koller, Morten Aagaard Petersen, Mirjam A. G. Sprangers	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact